# Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation

> **NCT01020175** · PHASE3 · COMPLETED · sponsor: **European Society for Blood and Marrow Transplantation** · enrollment: 350 (actual)

## Conditions studied

- Acute Leukemia
- Chronic Myelogenous Leukemia
- Myelodysplastic Syndrome

## Interventions

- **PROCEDURE:** Bone marrow transplantation
- **PROCEDURE:** Peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT01020175
- **Lead sponsor:** European Society for Blood and Marrow Transplantation
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-01
- **Primary completion:** 1999-12
- **Final completion:** 2002-12
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2009-11-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01020175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01020175, "Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01020175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*